Eudaimonia Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $273K | Buy |
5,036
+336
| +7% | +$18.2K | 0.15% | 140 |
|
|
2023
Q4 | $241K | Sell |
4,700
-111
| -2% | -$5.7K | 0.16% | 135 |
|
|
2023
Q3 | $279K | Sell |
4,811
-389
| -7% | -$22.6K | 0.2% | 123 |
|
|
2023
Q2 | $333K | Buy |
5,200
+251
| +5% | +$16.1K | 0.22% | 113 |
|
|
2023
Q1 | $343K | Sell |
4,949
-100
| -2% | -$6.93K | 0.23% | 112 |
|
|
2022
Q4 | $363K | Sell |
5,049
-87
| -2% | -$6.26K | 0.25% | 97 |
|
|
2022
Q3 | $365K | Sell |
5,136
-100
| -2% | -$7.11K | 0.25% | 88 |
|
|
2022
Q2 | $403K | Buy |
5,236
+564
| +12% | +$43.4K | 0.28% | 93 |
|
|
2022
Q1 | $341K | Buy |
+4,672
| New | +$341K | 0.2% | 116 |
|